Posts

Showing posts with the label Pharmacovigilance

Skill Development Programme on Pharmacovigilance for Medical Products (PvM)- 2020

Image
Sourse:  http://www.ipc.gov.in/news-highlights/724-skill-development-programme-on-pharmacopoeial-standards-for-pharmacovigilance-for-medical-products-pvm-2020.html

Big Pharma come together for better drug side effect detection

The Drug Safety Research Unit (DSRU) established the international group that consists of pharma giants such as Pfizer, Roche, BMS, Takeda, Lilly, Gilead, Alexion and Celgene to explore better ways of identifying adverse side effects from licensed medicines. The independent research unit, dubbed the International Working Group on Signal Detection and Management in Pharmacovigilance, convened an initial meeting of 40 international members from around the world to represent each pharmaceutical company, along with regulatory authorities and academic institutions. The gathering - which took place in London, UK - explored key topics, such as how big data and Artificial Intelligence can aid signal detection in monitoring the safety of medicines in clinical use. Peter De Veene, executive director, global drug safety at Alexion Pharmaceuticals, said: “Coming together as a multi-expert group provides the opportunity to find solutions to make the process of pharmacovigilance more ...

Last few days for registrations of Certificate course on IPR and Pharmacovigilance

We are closing with the registrations of IPR and Pharmacovigilance courses on Sunday.  Hurry up to confirm your registration. Final year B. Pharm students get our Online GPAT test series completely free of cost with the admission to any of one courses. IPR Course: http://pharmaliterati.blogspot.com/2018/06/cpipr-enters-3rd-batch-july-to-october.html Pharmacovigilance course: http://pharmaliterati.blogspot.com/2018/06/online-certificate-course-in.html

Walk-in interview on 9th to 11th April 2018_TCS Mumbai Pharmacovigilance

Image

IPC to hold workshop on 'Establishment of Pharmacovigilance System in Pharmaceutical Industries" on Aug 31 at Chandigarh

The Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre-Pharmacovigilance Programme of India (PvPI), will organise a workshop on " Basics of Pharmacovigilance & Establishment of Pharmacovigilance System in Pharmaceutical Industries - A Way Forward " on August 31, 2017 at PGIMER, Chandigarh.  The main objective of this 2nd regional workshop is to sensitize manufacturers, importers, distributors and other stakeholders about the need for a properly-designed Pharmacovigilance system across the user domain, to monitor Adverse Drug Reactions (ADRs) aimed at establishing safer drug use in the country. The workshop is aimed at bringing together regulatory authorities and pharma professionals/experts to discuss the practice of pharmacovigilance in the country. It will also widen the knowledge spectrum of pharma professionals in the field of pharmacovigilance.  Professionals in pharmacovigilance, quality assurance (QA) and regulatory affairs...

IPC to conduct skill development programme on pharmacovigilance from Jan 2017 onwards

National Coordination Center (NCC) for Pharmacovigilance Programme of India (PvPI), Indian Pharmacopoeia Commission (IPC) under the Union health ministry is going to organise "Skill Development Programme on Basics and Regulatory Aspects of Pharmacovigilance" from January 2017 onwards to accomplish the skill development programme in the country under the government’s ambitious Pradhan Mantri Kaushal Vikas Yojana. This will impart hands on training to the young healthcare professionals in the field of pharmacovigilance. The programme aims to enhance the knowledge and skill of qualified pharmacovigilance professionals working for ensuring better patient safety as per the requirement of Schedule Y of Drug and Cosmetics Act, 1940. Pharmacovigilance (PV) is a science that relates to detection, assessment, understanding and prevention of adverse affects or any other drug related problem. To track adverse drug reactions (ADRs.in Indian population, Union health ministry la...